Related to ExcellGene Extends Supply Agreement for Polyplus-Transfection's Reagents

• Sigma-Aldrich Expands In Vivo Biology Offerings through Purchase of Ace Animals
  
• Genzyme and Arecor Ally to Advance Protein Therapeutics
  
• Plant-Based Protein Production System Developed
  
• Esperion Taps TransGenRx for Protein Production to Support HDL-Related Research
  
• Life Technologies Inks Multiple Out-Licensing Deals for CHO Cell Lines
  
• SAFC Adds 50,000 Square Feet to Jerusalem Site to Bump Up Fermentation Capabilities
  
• Techulon Licenses Theranostic Transfection Reagent from Virginia Tech
  
• Merck BioManufacturing Network to Supply Anthera with Peptibody
  
• Horizon and University of Washington Partner to Apply Gene Editing to IPSCs
  
• Illumina Acquires Epicentre to Own Sequencing Library Preparation Technology
  
• BD Extends Reagent Supply Contract with Abaxis
  
• Ion Torrent to Provide Assembly and Analysis Solutions from DNAStar
  
• BioCat to Distribute SwitchGear Genomics’ LightSwitch Luciferase Assay System
  
• Platypus Licenses Cell Exclusion Zone Technology to Cell Biolabs
  
• Geospiza and NuGEN to Combine Technologies for Next-Gen Sequencing Sample Prep Workflow
  
• Ventana Licenses Cell Signaling’s EGFR IP and Antibodies for Tissue-Based IVDs
  
• Integrated DNA Technologies to Custom Manufacture Quanta Biosciences' miRNA Assays
  
• Sangamo Offers to Sell 6.7M Shares of Common Stock
  
• Ariad Inks Three Separate Deals Covering Argent Technology
  
• OncoMed and Bayer HealthCare Sign Manufacturing Deal for Partnered Wnt Inhibitor